You are here

Home » Reports

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 1 - 10 of 65 results
 
  • Record 1 TO 65

  1. Accommodation integrated technology to minimize the impact of disability on students' assessment

    SBC: 3-C Institute for Social Development, Inc.            Topic: N/A

    There is growing interest in computerized systems to increase accessibility of assessments for students with disabilities. Technology offers an ideal platform for implementing Universal Design (UD) principles for assessment to better accommodate student diversity and support broad student participation. The goal of this Phase II SBIR project is to continue the research and development of Assess2Pr ...

    SBIR Phase II 2014 Department of Education

  2. Water Purification using TiO2 and Novel Activation Method

    SBC: Imaging Systems Technology, Inc.            Topic: A

    Under this Phase II SBIR, Imaging Systems Technology (IST) will optimize and scale up its UV Plasma- shells with Titanium (IV) Dioxide (TiO2) system to produce a low cost, rugged, lightweight, and highly efficient and versatile water purification system. Plasma-shells are tiny hollow gas encapsulating devices ranging in size from 400 microns to 8.00 mm. Under the EPA Phase I SBIR, IST has successf ...

    SBIR Phase II 2014 Environmental Protection Agency

  3. Developing Intravesical Liposomes for Interstitial Cystitis

    SBC: Lipella Pharmaceuticals Inc.            Topic: NIDDK

    DESCRIPTION (provided by applicant): Lipella Pharmaceuticals Inc. (Pittsburgh, PA) is a clinical-stage pharmaceutical company specializing in intravesical therapies for urinary bladder dysfunctions. Lipella is submitting a research proposal to the Small Business Technology Transfer program titled Developing Intravesical Liposomes for Interstitial Cystitis . The project proposes to evaluate the sa ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health

  4. CONTRACT # N44CO-2014-00003C P.O.P. 5/15/2014-5/14/2015; IND ENABLING DEVELOPMENT OF NANOGMP: TARGETED; PURPOSE: TO PROVIDE FY14 FUNDING FOR SBIR PHASE II AWARD

    SBC: QUALIBER, INC.            Topic: NCI

    Not Available

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health

  5. IGF::OT::IGF SBIR Topic 314 Phase II- 3D Human Tumor Co-culture System for Accurate Prediction of Clinical Efficacy.

    SBC: KIYATEC, LLC            Topic: NCI

    Not Available

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health

  6. HHSN261201400049C; TOPIC 309- DEVELOPMENT OF LOW COST, SMALL SAMPLE MULTI-ANALYTE TECHNOLOGIES FOR CANCER DIAGNOSIS, PROGNOSIS AND EARLY DETECTION; TITLE: LOW-VOLUME, ULTRA-SENSITIVE IMMUNODIAGNOSTIC

    SBC: SILOAM BIOSCIENCES            Topic: NCI

    Not Available

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health

  7. Arise: An Online Relapse Prevention Tool for Substance Abusers

    SBC: 3-C Institute for Social Development, Inc.            Topic: NIDA

    Modify Phase I product and develop the full Arise product. Modify initial prototype based on feedback and fully develop all six modules. PUBLIC HEALTH RELEVANCE

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health

  8. A Novel Therapeutic for Invasive Candidiasis

    SBC: FOX CHASE CHEMICAL DIVERSITY CENTER INC.            Topic: NIAID

    DESCRIPTION (provided by applicant): Systemic fungal infections are increasingly common, especially in immune compromised patients. While new antifungal drugs have been developed, there is still a high mortality associated with these infections, especiallythose due to Candida albicans, other non-albicans species (NAS). This is due to the limited spectrum of the drugs, significant side effects, as ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health

  9. Helium Free MRI Image Guided Radiation Therapy (IGRT) System for ViewRay Inc

    SBC: HYPER TECH RESEARCH INC            Topic: NCI

    ? DESCRIPTION (provided by applicant): This NIH Bridge Grant will result in a conduction cooled, liquid helium free, MRI background magnet for a commercial image guided radiation treatment (IGRT) for cancer treatment. The program will ensure the successful continued commercialization of our customer's image guided radiation therapy (IGRT) system, a vital cancer treatment device now treati ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health

  10. Evaluation Of A Novel Connexin-Based Peptide For The Treatment Of Diabetic Wounds

    SBC: FirstString Research, Inc            Topic: NIDDK

    Project Summary/Abstract According to the ADA, 25.8 million children and adults have diabetes. Diabetics have an increased risk of complications such as heart disease and are prone to impaired wound healing. A major cause of morbidity and hospitalizationis diabetic foot ulceration (DFUs) that may result in infection, gangrene, amputations requiring prolonged hospitalization, costly treatments, an ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government